Aug 26, 2020 / 01:30AM GMT
Paul Brennan - PolyNovo Limited - CEO, MD & Director
Good morning, everybody. This is Paul Brennan, Managing Director of PolyNovo. With me today is Jan Gielen, our CFO; and David Williams, our Chairman.
Apologies first up, for the delay this morning, a few technical issues on our end. The results are now launched with the ASX, both this presentation and other 4-A and the annual report, and I encourage you to download those and look at those.
But we'll start this presentation, which is a summary. And then at the end, we'll take some Q&As. The format this morning is that I will show you through the highlights of the commercial activities and R&D, et cetera. And then we'll pass over to Jan for financial slides and then come back with FY '21 outlook and question and answers.
Next slide, please. So if we look at the revenues for the year with NovoSorb BTM revenues have been up on FY '19 to be 104%, up year-on-year. This has been a very good result, particularly given the COVID situation globally; and our second half was actually stronger than our first half, which is
Full Year 2020 Polynovo Ltd Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers